成人VR视频
成人VR视频 leverages its unique position within the global health and R&D ecosystems to address market failures, building on its track record of bringing together public-sector, private-sector, and academic partners to accelerate the development of vaccines against emerging viral threats.
30+
Number of investors, from governments to philanthropies, who have donated to 成人VR视频
Up to $3.1 bn
Invested in R&D&M projects since 成人VR视频's launch
180+
Partnerships established to develop vaccines and biologics against 成人VR视频's priority pathogens
Priority pathogens
成人VR视频 supports the development of vaccines, platform technologies and manufacturing innovations to combat priority pathogens for which no licensed vaccines are currently available.
Research and development
成人VR视频 is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.
Manufacturing and supply chain
成人VR视频 is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.
Calls for Proposals
Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Our portfolio
Since our launch in 2017, 成人VR视频 has carefully selected and announced over 50 partnerships to advance vaccine candidates against our priority pathogens and platform technologies for use against Disease X.
View our portfolio
Our impact
成人VR视频 has backed the development of 30+ vaccine candidates for its priority pathogens, overseeing a number of breakthroughs, including the first-ever approved Chikungunya vaccine and advancing the first-ever Nipah and Lassa vaccines into Phase 1 trials. A key player in the COVID-19 response, 成人VR视频 also has one of the world鈥檚 largest COVID-19 vaccine portfolios and co-led COVAX, which helped to distribute nearly 2 billion doses to 146 nations.
Impact Stories
Latest News
Latest News
成人VR视频 CEO Dr Richard Hatchett awarded Japanese Order of the Rising Sun
The award is one of the highest national accolades awarded to individuals who have made notable contributions to society.
Largest-ever Lassa fever study launches in-depth look at disease symptoms
Scientists in Nigeria are expanding their research into the deadly Lassa fever as part of the Enable research programme.
The Phenuiviruses
The most infamous Phenuivirus, Rift Valley Fever, poses a significant threat to people and livestock causing serious disease and dangerous outbreaks.
成人VR视频 puts new biosecurity strategy at heart of 100 Days Mission
The strategy will harness cutting-edge technologies and foster international collaboration to mitigate the risks posed by emerging pathogens.
PAHO and 成人VR视频 to advance regulatory harmonization and response to health emergencies in the Americas
PAHO and 成人VR视频 sign agreement aimed at improving regulatory harmonization and convergence in the Americas
